Hirudoid 3 Mg/G Topical Gel 40 G

Hirudoid (3 Mg / G Topical Gel 40 G)

ACTION AND MECHANISM

- Antithrombotic. Heparinoids such as chondroitin sulfate increase the activity of antithrombin III, giving rise to an anticoagulant effect. This anticoagulant effect is not evident after its topical administration, but they favor the reabsorption of local hematomas.

INDICATIONS

- [VARICES]. Treatment of symptoms of varicose veins in adults, such as heaviness or tightness in the legs.
- [HEMATOMA]. Elimination of superficial bruises caused by blows in adults and children from 1 year.

POSOLOGY

- Adults, topical: apply a thin layer, 2-3 times a day.
- Children and adolescents under 18 years of age, topical: no dosage adjustment is required.
The safety and efficacy for the treatment of varicose veins in <18 years and hematomas in <1 year have not been evaluated.
- Elderly, topical: no dosage adjustment is required.
Duration of treatment: treatment of varicose veins will last for 1-2 weeks, but if after 5 days of treatment there is no improvement in symptoms, or they worsen, the patient's clinical condition should be evaluated.
Hematoma treatment is usually less than 10 days.
Missed dose: skip the dose and continue the usual treatment. Do not double the next dose.

POSOLOGY IN KIDNEY FAILURE

No specific dosage recommendations have been made.

POSOLOGY IN LIVER FAILURE

No specific dosage recommendations have been made.

RULES FOR THE CORRECT ADMINISTRATION

Apply to the skin with a light massage to promote its penetration.
In the case of varicose veins associated with thrombotic processes, apply without massage.
Avoid contact with eyes and mucosa, as well as on wounded, inflamed, irritated or infected skin. After each application, wash your hands with water.

CONTRAINDICATIONS

- Hypersensitivity to heparinoids or any other component of the drug.
- [HEMORRHAGE] activates or serious coagulation disorders.

PRECAUTIONS

- [THROMBOEMBOLISM]. Apply the product directly, without massage.

ADVICE TO THE PATIENT

- Apply with a light massage. If you have a thrombosis process, apply without massage.
- Avoid contact with the eyes and mucosa. Do not apply to areas of skin with wounds, irritations, or symptoms of inflammation or infection.
- The duration of treatment is usually 1-2 weeks in varicose veins and <10 days in bruises. If after 5 days of varicose vein treatment, symptoms do not improve or worsen, contact your doctor and / or pharmacist.
- In case you forget to apply a dose, continue with your treatment. Do not double the next dose.

INTERACTIONS

They have not been described.

PREGNANCY

Animal safety : no teratogenic or embryotoxic effects have been observed in animals.

Safety in humans : Adequate and well-controlled studies in humans are not available. Its administration is only accepted if there are no safer therapeutic alternatives, and the benefits outweigh the possible risks.

Effects on fertility : No specific studies on its effects on fertility have been performed.

LACTATION

It is unknown whether it is excreted in milk, and the consequences it could have for the infant. Is recomended to suspend the lactancy or evy the administration.

CHILDREN

The safety and efficacy have not been evaluated for the treatment of varicose veins in children and adolescents under 18 years of age, nor for the treatment of bruises in children under 1 year of age, therefore its use is recommended.

ELDERLY

No specific problems have been described in the elderly that require a dosage adjustment.

EFFECTS ON DRIVING

They have not been described.

ADVERSE REACTIONS

It is usually well tolerated and only occasionally local adverse reactions may appear in the area of ​​application.
Adverse reactions are described according to each frequency interval, being considered very frequent (> 10%), frequent (1-10%), infrequent (0.1-1%), rare (0.01-0.1%) , very rare (<0.01%) or of unknown frequency (cannot be estimated from the available data).
- Allergic: very rare [HYPER-SENSITIVITY REACTIONS] local, with [ITCHING] or [SKIN IRRITATION], which usually disappear when treatment is stopped.

ADVERSE REACTIONS RELATED TO EXCIPIENTS

- This medicine contains propylene glycol, so it can cause [SKIN IRRITATION].

- Because it contains butyl hydroxytoluene as an excipient, it can produce local skin reactions, such as [CONTACT DERMATITIS], [EYE IRRITATION] or [SKIN IRRITATION] on mucous membranes.

OVERDOSE

Symptoms: there is no experience in poisoning.
Treatment: symptomatic.

Leaflet Hirudoid 3 Mg / G Topical Gel 40 G